Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms
Ieva Lase, Eir Löfgren, Agnes Hegedus, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson · 2026
Read Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms by Ieva Lase, Eir Löfgren, Agnes Hegedus, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13280542.txt.
Description
Ieva Lase and team report a 2026 study of hormone secretion as a prognosis sign in lung neuroendocrine neoplasms. These lung tumours can secrete hormones, though ectopic secretion is rare and poorly explored. New evidence hints that secreting tumours carry a worse prognosis. A look back cohort of one hundred sixty seven patients, without small cell lung cancer, was checked for clinical and biochemical data and outcome. Tumour tissue was checked for serotonin and calcitonin levels.
Among one hundred twenty seven patients with hormone measures, fifty two had raised levels. The serotonin metabolite 5-HIAA led, then calcitonin. High calcitonin levels strongly correlated with calcitonin in tumour tissue. Serotonin in tissue did not correlate with metabolite levels. Diffuse calcitonin staining went with shorter overall survival. Secreting tumours had shorter survival than non secreting ones, about sixty two versus one hundred twenty four months.
Catalog record
| CREATOR | Ieva Lase, Eir Löfgren, Agnes Hegedus, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36323 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |